IFNA2 and melanoma: To study the mechanisms of action of IFNα-2b (IntronA) in adjuvant immunotherapy of metastatic melanoma we investigated the expression of TAP1 in peripheral blood mononuclear cells (PBMCs) of 18 patients diagnosed with UICC stage III malignant melanoma.